Stephan S. Jackman
Equibles does not estimate personal net worth.
Get an email with a short summary when Alzamend Neuro, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALZN alertsAbout Stephan S. Jackman
Stephan S. Jackman is recorded as CEO at Alzamend Neuro, Inc. (ALZN). The proxy statement of Alzamend Neuro, Inc. reports total compensation of $468,288 for Stephan S. Jackman in fiscal 2025, including a base salary of $350,000. Disclosed compensation is on record for 5 fiscal years. Alzamend Neuro, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alzamend Neuro, Inc. includes David J. Katzoff (CFO) and Milton C. Ault, III (Board Member).
Affiliation history
-
Current
Company network
Leadership on record at Alzamend Neuro, Inc.
- David J. Katzoff CFO
- Milton C. Ault, III Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alzamend Neuro, Inc. (ALZN) | Chief Executive Officer | $350,000 | $468,288 |
| 2024 | Alzamend Neuro, Inc. (ALZN) | Chief Executive Officer | $350,000 | $443,617 |
| 2023 | Alzamend Neuro, Inc. (ALZN) | Chief Executive Officer | $300,000 | $2,223,611 |
| 2022 | Alzamend Neuro, Inc. (ALZN) | Chief Executive Officer | $303,125 | $473,125 |
| 2021 | Alzamend Neuro, Inc. (ALZN) | Chief Executive Officer | $225,000 | $225,000 |
Recent activity
No call appearances or filed executive changes recorded yet.